Taylor Zhang

Taylor Zhang is a Director in Product and Analytical Department in Cell Therapy Development and Operations at Bristol Myers Squibb, in Seattle, Washington. Prior to Bristol Myers Squibb, he was a Principal Scientist and group leader in the Protein Analytical Chemistry Department at Genentech. He received his PhD in Analytical Chemistry from Iowa State University.

Taylor Zhang

Articles by Taylor Zhang

  • Characterization of DNA Impurities in Cell Therapies

    Wednesday, February 24, 2021
    T cells play important roles in adaptive immunity by serving as sentinels against foreign pathogens. T cells that have been engineered to recognize cancer-specific antigens present a promising treatment option for a number of... read more
  • <<
  • >>